{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:41:03Z","timestamp":1790293263402,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2990,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.bbmt.2006.09.012","type":"journal-article","created":{"date-parts":[[2007,1,21]],"date-time":"2007-01-21T07:08:28Z","timestamp":1169363308000},"page":"206-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"13","author":[{"given":"Jason","family":"Tay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Tinmouth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Huebsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2006.09.012_bib1","series-title":"Hematology: Basic Principles and Practice","first-page":"1728","article-title":"Hematology: basic principles and practice; transplantation","author":"Hoffman","year":"2004"},{"key":"10.1016\/j.bbmt.2006.09.012_bib2","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.012_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2006.09.012_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00062752-200311000-00010","article-title":"Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment","volume":"10","author":"Wadleigh","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib5","first-page":"75","article-title":"Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia","volume":"17","author":"Rozman","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1700895","article-title":"Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution","volume":"20","author":"Kami","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2006.09.012_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2006.09.012_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01695888","article-title":"On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease","volume":"66","author":"Carreras","year":"1993","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib10","first-page":"439","article-title":"A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation","volume":"10","author":"Blostein","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bbmt.2006.09.012_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4065\/78.5.589","article-title":"Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation","volume":"78","author":"Kumar","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bbmt.2006.09.012_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","article-title":"Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation","volume":"74","author":"Gluckman","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bmt.1701321","article-title":"Parenteral glutamine protects hepatic function during bone marrow transplantation","volume":"22","author":"Brown","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9343(00)00318-1","article-title":"Ursodeoxycholic acid therapy in hepatobiliary disease","volume":"108","author":"Kowdley","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2006.09.012_bib18","first-page":"637","article-title":"Management of gallstones","volume":"72","author":"Bellows","year":"2005","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.bbmt.2006.09.012_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2036.2005.02318.x","article-title":"Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years","volume":"21","author":"Chan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bbmt.2006.09.012_bib20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2006.09.012_bib21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"issue":"12 pt 1","key":"10.1016\/j.bbmt.2006.09.012_bib22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2006.09.012_bib23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2006.09.012_bib24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.7326\/0003-4819-116-8-624","article-title":"Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver","volume":"116","author":"Fried","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2006.09.012_bib25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1399-0012.2005.00424.x","article-title":"Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver","volume":"19","author":"Arat","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib26","first-page":"191","article-title":"Effect of ursodeoxycholic acid on hypertransaminasaemia and bile acid composition in patients undergoing bone marrow transplantation\u2014a double-blind randomized control study","volume":"28","author":"Clerici","year":"1996","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib27","first-page":"367","article-title":"Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients","volume":"10","author":"Essell","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2006.09.012_bib28","first-page":"157","article-title":"Management of hepatic veno-occlusive disease (VOD) in pediatric patients: retrospective analysis in 6 AIEOP-BMT (Italian Pediatric Hematology Oncology Association-Bone Marrow Transplantation Group) centers","volume":"18","author":"Miniero","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 1, pt 1","key":"10.1016\/j.bbmt.2006.09.012_bib29","first-page":"276a","article-title":"The Japanese multicentre open randomized trial of prophylactic ursodeoxycholic acid for veno-occlusive disease of the liver in patients undergoing stem cell transplantation","volume":"92","author":"Ohashi","year":"1998","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2006.09.012_bib30","first-page":"S224","article-title":"Ursodiol for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"23","author":"Ruutu","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib31","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.012_bib32","series-title":"Systematic Reviews to Support Evidence-Based Medicine: How to Review and Apply Findings of Healthcare Research","author":"Khan","year":"2003"},{"key":"10.1016\/j.bbmt.2006.09.012_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.bbmt.2006.09.012_bib34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2006.09.012_bib35","first-page":"250a","article-title":"A randomized double-blind trial of prophylactic ursodeoxycholic acid (UDCA) vs placebo to prevent veno-occlusive disease of the liver (VOD) in patients undergoing allogeneic bone marrow transplantation (BMT)","volume":"84","author":"Essell","year":"1994","journal-title":"Blood"},{"issue":"suppl 1, pt 1","key":"10.1016\/j.bbmt.2006.09.012_bib36","first-page":"276","article-title":"The japanese multicenter open randomized trial of prophylactic ursodeoxycholic acid for veno-occlusive disease on the liver n patients undergoing stem cell transplantation","volume":"92","author":"Ohashi","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.012_bib37","first-page":"1114","article-title":"Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy","volume":"87","author":"Giles","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2006.09.012_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbmt.2004.06.004","article-title":"A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Thornley","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-144-6-200603210-00007","article-title":"A risk score for mortality after allogeneic hematopoietic cell transplantation","volume":"144","author":"Parimon","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2006.09.012_bib42","first-page":"225","article-title":"Association of busulfan area under the curve with veno-occlusive disease following BMT","volume":"17","author":"Dix","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/bbmt.2002.v8.pm12374454","volume":"8","author":"Kashyap","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbmt.2005.12.028","volume":"12","author":"Kletzel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00277-004-0982-4","article-title":"Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation","volume":"84","author":"Lee","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbmt.2004.07.010","article-title":"Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation","volume":"10","author":"Tran","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib47","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","article-title":"Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation","volume":"101","author":"McDonald","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.012_bib48","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","first-page":"769","article-title":"Gastrointestinal and hepatic complications","author":"Strasser","year":"2004"},{"key":"10.1016\/j.bbmt.2006.09.012_bib49","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0049-3848(92)90054-E","article-title":"Acute t-PA release by defibrotide","volume":"66","author":"Klocking","year":"1992","journal-title":"Thromb Res"},{"key":"10.1016\/j.bbmt.2006.09.012_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00609244","article-title":"Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man","volume":"35","author":"Coccheri","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0038-1642468","article-title":"Defibrotide stimulates expression of thrombomodulin in human endothelial cells","volume":"71","author":"Zhou","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bbmt.2006.09.012_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-2007-1000400","article-title":"Defibrotide reduces monocyte PAI-2 and procoagulant activity","volume":"21","author":"Abbate","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.bbmt.2006.09.012_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(93)90864-E","article-title":"Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist","volume":"238","author":"Bianchi","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199345020-00007","article-title":"Defibrotide","volume":"45","author":"Palmer","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2006.09.012_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/oli.2006.16.105","article-title":"Defibrotide, a polydisperse mixture of single-stranded phosphodiester oligonucleotides with lifesaving activity in severe hepatic veno-occlusive disease: clinical outcomes and potential mechanisms of action","volume":"16","author":"Kornblum","year":"2006","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.bbmt.2006.09.012_bib56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bmt.1701650","article-title":"Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation","volume":"23","author":"Abecasis","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib57","first-page":"1122","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.012_bib59","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.012_bib60","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.012_bib61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00432-001-0316-z","article-title":"Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation\u2014successful treatment with high-dose methylprednisolone and defibrotide","volume":"128","author":"Sayer","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib62","first-page":"55","article-title":"Successful treatment with defibrotide for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"51","author":"Yakushijin","year":"2005","journal-title":"Kobe J Med Sci"},{"key":"10.1016\/j.bbmt.2006.09.012_bib63","first-page":"34","article-title":"Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange","volume":"16","author":"Besisik","year":"2005","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib64","first-page":"795","article-title":"Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III\/defibrotide therapy","volume":"91","author":"Haussmann","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2006.09.012_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02782200","article-title":"Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide","volume":"17","author":"Jenner","year":"2000","journal-title":"Med Oncol"},{"key":"10.1016\/j.bbmt.2006.09.012_bib66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106006689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106006689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:27:06Z","timestamp":1761056826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879106006689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1083879106006689"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.09.012","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}